Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 30% ± 8% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2904.16 | 459 / 459 | 100% | 17.57 | 1118 / 1118 |
esophagus | 100% | 2527.89 | 1445 / 1445 | 100% | 13.60 | 183 / 183 |
ovary | 100% | 2726.67 | 180 / 180 | 100% | 10.89 | 430 / 430 |
prostate | 100% | 3161.08 | 245 / 245 | 100% | 19.46 | 502 / 502 |
stomach | 100% | 2331.93 | 359 / 359 | 100% | 14.70 | 286 / 286 |
lung | 100% | 2502.11 | 578 / 578 | 100% | 12.58 | 1153 / 1155 |
intestine | 100% | 2564.83 | 966 / 966 | 100% | 15.60 | 526 / 527 |
bladder | 100% | 2622.33 | 21 / 21 | 100% | 13.32 | 502 / 504 |
uterus | 100% | 2771.04 | 170 / 170 | 100% | 12.45 | 457 / 459 |
pancreas | 100% | 2270.63 | 328 / 328 | 99% | 11.56 | 177 / 178 |
thymus | 100% | 3616.85 | 653 / 653 | 99% | 13.69 | 601 / 605 |
skin | 100% | 3035.24 | 1809 / 1809 | 99% | 12.54 | 465 / 472 |
brain | 98% | 1615.21 | 2602 / 2642 | 100% | 11.32 | 704 / 705 |
kidney | 100% | 1917.84 | 89 / 89 | 98% | 8.88 | 885 / 901 |
adrenal gland | 100% | 3219.75 | 258 / 258 | 97% | 10.23 | 222 / 230 |
liver | 100% | 1513.48 | 226 / 226 | 94% | 7.11 | 383 / 406 |
adipose | 100% | 2452.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.19 | 29 / 29 |
muscle | 100% | 5448.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2406.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.24 | 1 / 1 |
blood vessel | 100% | 2516.83 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1791.62 | 840 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 9.61 | 77 / 80 |
peripheral blood | 74% | 1195.37 | 690 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051607 | Biological process | defense response to virus |
GO_0042797 | Biological process | tRNA transcription by RNA polymerase III |
GO_0045087 | Biological process | innate immune response |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005666 | Cellular component | RNA polymerase III complex |
Gene name | POLR3E |
Protein name | DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit C5) (DNA-directed RNA polymerase III 80 kDa polypeptide) RNA polymerase III subunit E |
Synonyms | KIAA1452 |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates . Specific peripheric component of RNA polymerase III (Pol III) which synthesizes small non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci. Assembles with POLR3D/RPC4 forming a subcomplex that binds the Pol III core. Enables recruitment of Pol III at transcription initiation site and drives transcription initiation from both type 2 and type 3 DNA promoters. Required for efficient transcription termination and reinitiation (By similarity). Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway . . |
Accessions | ENST00000563024.5 H3BSI5 H3BSM3 ENST00000564750.5 H3BMR4 ENST00000359210.8 [Q9NVU0-2] ENST00000299853.10 [Q9NVU0-1] ENST00000565358.5 H3BRY1 A0A0C4DH01 ENST00000639550.2 [Q9NVU0-1] H3BNJ0 ENST00000640588.2 [Q9NVU0-1] Q9NVU0 ENST00000564209.5 [Q9NVU0-4] ENST00000564883.5 ENST00000569757.1 ENST00000561494.5 H3BM46 H3BS41 ENST00000565551.5 ENST00000418581.6 [Q9NVU0-5] ENST00000615879.4 |